New screening method identifies inhibitors of cancer cell metabolism

A new screening system developed by scientists at the UCLA Jonsson Comprehensive Cancer Center leverages redundancy in an important component of a cellnucleotide metabolismto help identify new drugs that specifically and potently block processes that are essential for cancer cell growth.